A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity

Clinical trial NCT07721597 · RECRUITING

Trial details

NCT number: NCT07721597
Sponsor: Zealand Pharma
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Participants Study Overweight and Obese Adults First in Man Study to Evaluate Initial Safety

Start date: 2026-07-09
Primary completion: 2027-09-06
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.